dysgeusia/zhubný nádor

Odkaz sa uloží do schránky

Vyberte typ zoradenia

Strana 1 od 175 výsledky

Treatment-related dysgeusia in head and neck cancer patients.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Head and neck cancer patients treated with radiotherapy and/or chemotherapy agents may develop altered taste acuity. This, together with radiation induced xerostomia and dysphagia, is a major contributory factor to the anorexia and concomitant morbidity often seen in this group of patients. This

[Taste dysfunction (dysgeusia) and radioiodine therapy of thyroid cancer - Be aware of side effects by antidepressants and sedatives].

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

In addition to xerostomia, taste dysfunction (hypo-, dysgeusia) is an independent side effect of radioiodine therapy of thyroid cancer. Hypogeusia results from damage of the small mucous salivary glands in the vicinity of the taste buds. Particularly in those patients, who are treated with drugs

[Taste dysfunction (dysgeusia) and radioiodine therapy of thyroid cancer - be aware of side effects by antidepressants and sedatives. Vorschädigung durch Antidepressiva und Sedativa beachten].

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Baseline Dysgeusia in Chemotherapy-Naïve Non-Small Cell Lung Cancer Patients: Association with Nutrition and Quality of Life.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Purpose: Dysgeusia can be found in 50% of cancer patients undergoing chemotherapy. Nonetheless, dysgeusia can be present in treatment-naïve patients, and may negatively impact nutrition and quality of life. Methods: Treatment-naïve non-small cell lung cancer (NSCLC) was assessed for

Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

We describe a case of dysgeusia that developed gradually over one week after initiation of crizotinib administration for treatment of ALK-positive non-small cell lung cancer, necessitating discontinuation of the agent. The symptom was accompanied by progressive loss in appetite and body weight.

Dysgeusia in symptomatic syndrome of inappropriate antidiuretic hormone secretion: think of lung cancer.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The case of a 60-year-old woman who presented with marked dysgeusia to all food and symptomatic syndrome of inappropriate antidiuretic hormone secretion (SIADH) is described. She eventually turned out to have metastatic small cell lung cancer. The case study explores the interesting constellation of

Acupuncture Therapy in Post-Radiation Head-and-Neck Cancer with Dysgeusia

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Background: Radiation therapy for head-and-neck cancer can cause side-effects, including pain, nausea, vomiting, sensory disorders such as anosmia and dysgeusia, dysphagia, xerostomia, hot flashes, fatigue, sleep disorders, and even anxiety and depression disorders. Therapies using

Photobiomodulation Therapy in the Treatment of Oral Mucositis, Dysgeusia and Oral Dryness as Side-Effects of Head and Neck Radiotherapy in a Cancer Patient: A Case Report.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Successful management of oral mucositis, dysgeusia and oral dryness was made with fivesessions of photobiomodulation. The severity of oral mucositis was measured according to the World Health Organization scale for the assessment of oral mucositis. Dysgeusia testing was performed according to the

A systematic review of dysgeusia induced by cancer therapies.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

OBJECTIVE The purpose was to review relevant scientific papers written since 1989 which focused on the prevalence and management of dysgeusia as an oral side effect of cancer treatment. METHODS Our literature search was limited to English language papers published between 1990 and 2008. A total of

Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and Cabazitaxel.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

BACKGROUND We hypothesized that the adverse event (AE) profile of cabazitaxel with regard to alopecia, nail changes, neuropathy, and dysgeusia differs from docetaxel. METHODS Prospectively collected data on treatment-emergent AEs (frequency and grade [G]) from clinical trial databases of docetaxel

Temporal lobe tumor manifested by localized dysgeusia.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Undiagnosed lung cancer presenting with dysgeusia.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Drug-related Dysgeusia: A Systematic Review.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Dysgeusia is an unpleasant alteration in taste. It can affect the nutritional and psychological status and decrease the quality of life of patients. It may be caused by nerve injury, head and neck trauma or surgery, infections, radiotherapy and drugs, but certain aetiological factors

Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99mTc-NC100692.

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The present study was a proof-of-concept study to provide an initial indication of the efficacy and safety of imaging malignant breast tumors using (99m)Tc-NC100692. The agent is a small peptide with high affinity for integrin receptors that are upregulated and expressed preferentially on

Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The poly(ADP-ribose) polymerase inhibitor rucaparib is approved as monotherapy in the treatment and maintenance settings for women with relapsed ovarian cancer in the European Union and the United States. We review the safety profile of rucaparib in both settings and provide recommendations for the

Predchádzajúce
1
2
3
4
5
6
...
11
12
Ďalšie

Pripojte sa k našej
facebookovej stránke

Herbal & Natural Medicine

Najkompletnejšia databáza liečivých bylín podporovaná vedou

Pracuje v 55 jazykoch
Bylinné lieky podporené vedou
Rozpoznávanie bylín podľa obrázka
Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
Vyhľadajte liečivé byliny podľa ich účinkov
Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume